Search / 40 results found

from
to
  • Updated

JACKSONVILLE, Fla., Oct. 19, 2021 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Jacksonville metropolitan area. Conveniently located in the communities of Mandarin, Avondale, and Tinseltown, IVX Health offers patients an alternative to hospital-based infusions – with the same high-quality standards and safety protocols. IVX Health reimagines the traditional experience for infusion patients with amenities such as guaranteed private suites that allow for proper social distancing and convenient locations often only a few miles from home or work.

  • Updated

OSAKA, Japan and NASHVILLE, Tenn., Oct. 18, 2021 /PRNewswire/ -- Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura; Securities Code: 4506, First Section of TSE) and BehaVR, Inc.,(Head Office: TN, U.S.) announce today that the companies have signed definitive agreements to develop and commercialize both prescription digital therapeutics and general wellness products for treatment of Social Anxiety Disorder (SAD), Generalized Anxiety Disorder (GAD), and Major Depressive Disorder (MDD) with the goal of bringing much needed tools to tackle the escalating global anxiety and depression crisis.

  • Updated

NASHVILLE, Tenn., Oct. 15, 2021 /PRNewswire/ -- ChanceLight® Behavioral Health, Therapy and Education ("ChanceLight") announced it has appointed Patricia Boyer Miller to the company's Board of Directors. ChanceLight is a portfolio company of The Halifax Group, a leading private equity firm that partners with management to invest in entrepreneurial companies.